XML 403 R123.htm IDEA: XBRL DOCUMENT v3.23.1
Financial Instruments - Narrative - Convertible note from associate (Details)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2022
USD ($)
Jul. 27, 2022
USD ($)
$ / shares
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Short-term note [Line Items]        
Current receivables due from associates $ 0   $ 0 $ 15,120
Financial assets $ 575,738   $ 575,738 $ 944,832
Gelesis        
Short-term note [Line Items]        
Exercise price (in dollars per share) | $ / shares   $ 0.01    
Calculation of number of securities called by warrants or rights, multiplier   0.2    
Calculation of number of securities called by warrants or rights, number of trading days   5 days    
Convertible note receivable | Discount rate        
Short-term note [Line Items]        
Weighted Average 0.289   0.289  
Percentage of reasonably possible increase in unobservable input, assets 5.00%   5.00%  
Percentage of reasonably possible decrease in unobservable input, assets (5.00%)   (5.00%)  
Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, assets     $ 400  
Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, assets     400  
Convertible note receivable | Expected term        
Short-term note [Line Items]        
Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, assets     $ 900  
Sensitivity range, increase 3 months   6 months  
Convertible note receivable | Gelesis        
Short-term note [Line Items]        
Current receivables due from associates   $ 15,000    
Current receivable due from associates, interest rate   15.00%    
Financial assets $ 16,500   $ 16,500  
Interest income on loans and receivables     963  
Gains (losses) on financial assets at fair value through profit or loss     $ 539